A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours
2000 ◽
Vol 11
(12)
◽
pp. 1579-1584
◽
H. Hirte
◽
R. Goel
◽
P. Major
◽
L. Seymour
◽
S. Huan
◽
...
2005 ◽
Vol 23
(5)
◽
pp. 437-443
◽
H. Hirte
◽
D. Stewart
◽
R. Goel
◽
E. Chouinard
◽
S. Huan
◽
...
2004 ◽
Vol 90
(4)
◽
pp. 800-804
◽
L Wall
◽
D C Talbot
◽
P Bradbury
◽
D I Jodrell
2004 ◽
Vol 55
(2)
◽
pp. 136-142
◽
André Planting
◽
Ate van der Gaast
◽
Patrick Schöffski
◽
Michele Bartkowski
◽
Coleta Verheij
◽
...
2001 ◽
Vol 48
(4)
◽
pp. 269-274
◽
Elisabeth Heath
◽
Seamus O'Reilly
◽
Rachel Humphrey
◽
Pavur Sundaresan
◽
Ross Donehower
◽
...
1997 ◽
Vol 33
◽
pp. S246
◽
2001 ◽
Vol 12
(3)
◽
pp. 389-395
◽
C. Erlichman
◽
A.A. Adjei
◽
S.R. Alberts
◽
J.A. Sloan
◽
R.M. Goldberg
◽
...
G.S. Falchook
◽
S. Fu
◽
H.M. Amin
◽
S.A. Piha-Paul
◽
D.S. Hong
◽
...
2007 ◽
Vol 13
(7)
◽
pp. 2091-2099
◽
Alberto A. Chiappori
◽
S. Gail Eckhardt
◽
Ronald Bukowski
◽
Daniel M. Sullivan
◽
Minoru Ikeda
◽
...
2012 ◽
Vol 48
(2)
◽
pp. 179-186
◽
Patrick Schöffski
◽
Ahmad Awada
◽
Herlinde Dumez
◽
Thierry Gil
◽
Sylvie Bartholomeus
◽
...
I. Colombo
◽
S. Genta
◽
F. Martorana
◽
M. Guidi
◽
E.S.P. Samartzis
◽
...